Fate Therapeutics, Inc. (FATE)

NASDAQ: FATE · IEX Real-Time Price · USD

4.790

-0.250 (-4.96%)

At close: Apr 19, 2024, 4:00 PM

5.00

+0.21 (4.38%)

After-hours: Apr 19, 2024, 7:22 PM EDT

Fate Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-160.93	-281.72	-212.15	-173.39	-98.15	-66.6	-42.95	-33.46	-29.99	-25.88	Upgrade
Depreciation & Amortization	18.28	13.76	5.85	3.09	2.19	1.2	0.97	0.88	0.69	0.5	Upgrade
Share-Based Compensation	43.46	78.73	54.36	30.75	17.41	6.29	3.61	3.18	2.4	2.43	Upgrade
Other Operating Activities	-33.08	-58.98	-10.93	100.32	-4.63	20.45	1.56	-0.43	8.51	0.53	Upgrade
Operating Cash Flow	-132.26	-248.21	-162.87	-39.23	-83.18	-38.65	-36.82	-29.82	-18.4	-22.42	Upgrade
Capital Expenditures	-6.15	-35.57	-50.7	-4.93	-7.4	-2.3	-1.73	-0.44	-1.5	-0.88	Upgrade
Change in Investments	118.82	202.32	-273.32	-156.14	-150.06	1.84	-8.47	-3.68	0	0	Upgrade
Investing Cash Flow	112.67	166.75	-324.02	-161.08	-157.45	-0.46	-10.2	-4.11	-1.5	-0.88	Upgrade
Share Issuance / Repurchase	0.09	9.21	432.45	282.35	164.93	137.27	43.35	29.04	37.15	0.14	Upgrade
Debt Issued / Paid	0	0	0	0	-15	0	4.14	-7.69	-1.55	18.22	Upgrade
Other Financing Activities	-	-	20.68	0.49	-	3.51	-0.13	36.39	-	-	Upgrade
Financing Cash Flow	0.09	9.21	453.13	282.84	149.93	140.78	47.36	57.74	35.6	18.37	Upgrade
Net Cash Flow	-19.51	-72.25	-33.76	82.53	-90.7	101.67	0.34	23.8	15.71	-4.94	Upgrade
Free Cash Flow	-138.42	-283.77	-213.57	-44.16	-90.57	-40.95	-38.54	-30.26	-19.9	-23.3	Upgrade
Free Cash Flow Margin	-217.86%	-294.68%	-382.43%	-140.49%	-848.03%	-863.99%	-938.68%	-687.46%	-818.39%	-	Upgrade
Free Cash Flow Per Share	-1.41	-2.93	-2.25	-0.54	-1.33	-0.73	-0.92	-0.95	-0.78	-1.14	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).